Cancer Stories

The future of genetic testing

 

Until recently, cancer genetic testing was based on inspection of a few genes.

Patient experience in the cancer genetics clinic and beyond

 

An important piece of our program is the involvement of the Cancer Genetics team with the cancer support community and general patient education.

The GI genetics clinic and population-based screening for Lynch syndrome

 

The UT Southwestern Cancer Genetics program, in partnership with the Gastroenterology Division, has had a specialized high-risk GI Genetics Clinic at Parkland for the past six years.

Reaching rural communities

 

In addition to seeing patients inperson in the cancer center, UT Southwestern is seeking ways to expand beyond the boundaries of the cancer center to offer genetic counseling services to much of North Texas.

Population-based screening programs

 

Screening family histories to identify patients with Hereditary Breast and Ovarian Cancer syndrome (HBOC) has recently been classified as a Tier 1 health application by the Centers for Disease Control (CDC).

Gynecology/Oncology

 

Women with mutations in the HBOC genes or the Lynch syndrome genes are at an increased lifetime risk for ovarian and fallopian tube cancer.

Kim’s story: Surviving multiple myeloma

Kim’s story: Surviving multiple myeloma

 by 

When cancer struck Kim Ludwig’s family not once, but twice, she relied on her brave spirit and a clinical trial drug to save her life.

A Dynamic Decade

A Dynamic Decade

 

In 1988, a $41 million gift from Dallas businessman Harold Simmons and his wife, Annette, provided seminal funds to transform cancer research and care at UT Southwestern.

Facilities

Facilities

 

Dallas’ Medical District, about two miles west of downtown, is home to UT Southwestern Medical Center, including its Simmons Comprehensive Cancer Center and a number of facilities that support the Cancer Center’s mission, as well as several key partners in community cancer care.

Clinical Care

Clinical Care

 

Genetic testing in 2014 at the Simmons Cancer Center revealed that the 50-year-old had a mutation in the BRCA1 gene, meaning she had a higher risk for breast and ovarian cancer.